Sheena Linehan

Senior Associate - Patent Attorney

Location

Nottingham, UK
Telephone

+44 (0) 115 955 2211
Email me

sheena.linehan@potterclarkson.com

Download

My v-card
Connect with me
- Follow me on LinkedIn

Sheena advises on all aspects of patent practice and has notable expertise in drafting and prosecution of patent applications.

She also has a broad range of experience in strategic portfolio development and management, freedom-to-operate analysis, European opposition and appeal proceedings and obtaining supplementary protection certificates. Sheena works with a range of clients including multi-national companies, SMEs, start-ups and world-class universities.

Sheena regularly publishes articles relating to legal developments which affect the life sciences and medtech sectors.

She joined Potter Clarkson in 2004.

Specialisms

Biological and chemical technologies including vaccines, immunological therapies, diagnostics, genotyping and nucleic acid amplification techniques, therapeutic peptides and polypeptides, stem cell therapies, personalised medicine and further medical uses

Education

Sheena read natural sciences (biochemistry) at Cambridge University before obtaining a DPhil in immunology at Oxford University where she won a junior research fellowship to continue her research for a further year. She then went on to complete three years of postdoctoral research in microbial pathogenesis at Imperial College London.

She qualified as a Chartered Patent Attorney in 2008 and a European Patent Attorney in 2009.

Qualifications

MA (Cantab), DPhil, UK and European Patent Attorney

Memberships

Member of British Society of Immunology

Awards & Recognition

In 2006, Sheena was awarded the Moss Prize for obtaining the highest overall mark in the foundation level patent examination papers.

Interests

Sheena enjoys outdoor pursuits. She is an active member of a walking group and a volunteer gardener.

Sheena Linehan’s background as a biochemist and immunologist has proved to be of great benefit to our business when prosecuting patents. Quite simply we would not look elsewhere for advice." Legal 500, 2023